• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

QRICH1通过CARD11信号小体介导CD8 T细胞活化的细胞内检查点。

QRICH1 mediates an intracellular checkpoint for CD8 T cell activation via the CARD11 signalosome.

作者信息

Carter Nicole M, Hankore Wihib D, Yang Yong-Kang, Yang Chao, Hutcherson Shelby M, Fales Wyatt, Ghosh Anushka, Mongia Piyusha, Mackinnon Sophie, Brennan Anna, Leone Robert D, Pomerantz Joel L

机构信息

Department of Biological Chemistry and Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

Sci Immunol. 2025 Mar 14;10(105):eadn8715. doi: 10.1126/sciimmunol.adn8715.

DOI:10.1126/sciimmunol.adn8715
PMID:40085689
Abstract

Antigen receptor signaling pathways that control lymphocyte activation depend on signaling hubs and negative regulatory proteins to fine-tune signaling outputs to ensure host defense and avoid pathogenic responses. Caspase recruitment domain-containing protein 11 (CARD11) is a critical signaling scaffold that translates T cell receptor (TCR) triggering into the activation of nuclear factor κB (NF-κB), c-Jun N-terminal kinase (JNK), mechanistic target of rapamycin (mTOR), and Akt. Here, we identify glutamine-rich protein 1 (QRICH1) as a regulator of CARD11 signaling that mediates an intracellular checkpoint for CD8 T cell activation. QRICH1 associates with CARD11 after TCR engagement and negatively regulates CARD11 signaling to NF-κB. QRICH1 binding to CARD11 is controlled by an autoregulatory intramolecular interaction between QRICH1 domains of previously uncharacterized function. QRICH1 controls the antigen-induced activation, proliferation, and effector status of CD8 T cells by regulating numerous genes critical for CD8 T cell function. Our results define a component of antigen receptor signaling circuitry that fine-tunes effector output in response to antigen recognition.

摘要

控制淋巴细胞活化的抗原受体信号通路依赖于信号枢纽和负调节蛋白来微调信号输出,以确保宿主防御并避免致病性反应。含半胱天冬酶招募结构域蛋白11(CARD11)是一种关键的信号支架,可将T细胞受体(TCR)触发转化为核因子κB(NF-κB)、c-Jun氨基末端激酶(JNK)、雷帕霉素作用靶点(mTOR)和Akt的激活。在此,我们鉴定出富含谷氨酰胺蛋白1(QRICH1)是CARD11信号的调节因子,介导CD8 T细胞活化的细胞内检查点。TCR参与后,QRICH1与CARD11结合,并对CARD11向NF-κB的信号传导起负调节作用。QRICH1与CARD11的结合受功能未知的QRICH1结构域之间的自动调节分子内相互作用控制。QRICH1通过调节对CD8 T细胞功能至关重要的众多基因,控制CD8 T细胞的抗原诱导活化、增殖和效应状态。我们的结果确定了抗原受体信号通路的一个组成部分,该部分可根据抗原识别微调效应输出。

相似文献

1
QRICH1 mediates an intracellular checkpoint for CD8 T cell activation via the CARD11 signalosome.QRICH1通过CARD11信号小体介导CD8 T细胞活化的细胞内检查点。
Sci Immunol. 2025 Mar 14;10(105):eadn8715. doi: 10.1126/sciimmunol.adn8715.
2
The POSH scaffold protein is essential for signal coordination leading to CD8 T cell differentiation and survival.POSH支架蛋白对于导致CD8 T细胞分化和存活的信号协调至关重要。
Front Immunol. 2025 Jul 2;16:1630599. doi: 10.3389/fimmu.2025.1630599. eCollection 2025.
3
CARD11 signaling regulates CD8 T cell tumoricidal function.CARD11信号传导调节CD8 T细胞的杀瘤功能。
Nat Immunol. 2025 Jun 18. doi: 10.1038/s41590-025-02192-w.
4
MyD88 determines T cell fate through BCAP-PI3K signaling.髓样分化因子88(MyD88)通过BCAP-磷脂酰肌醇-3激酶(PI3K)信号通路决定T细胞命运。
J Immunol. 2025 Feb 23;214(3):433-45. doi: 10.1093/jimmun/vkae037.
5
A CARMIL2 gain-of-function mutation suffices to trigger most CD28 costimulatory functions in vivo.CARMIL2功能获得性突变足以在体内触发大多数CD28共刺激功能。
J Exp Med. 2025 Aug 4;222(8). doi: 10.1084/jem.20250339. Epub 2025 May 22.
6
BENTA disease or CARD11 gain-of-function? A novel variant with atypical features and a literature review.本塔病还是CARD11功能获得性突变?一种具有非典型特征的新型变异体及文献综述。
Immunol Lett. 2025 Oct;275:107005. doi: 10.1016/j.imlet.2025.107005. Epub 2025 Mar 27.
7
Molecular Determinants of Scaffold-induced Linear Ubiquitinylation of B Cell Lymphoma/Leukemia 10 (Bcl10) during T Cell Receptor and Oncogenic Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling.在T细胞受体和含半胱天冬酶招募结构域蛋白11(CARD11)信号传导过程中,支架诱导的B细胞淋巴瘤/白血病10(Bcl10)线性泛素化的分子决定因素
J Biol Chem. 2016 Dec 9;291(50):25921-25936. doi: 10.1074/jbc.M116.754028. Epub 2016 Oct 24.
8
From syndromic clues to diagnosis: understanding CARD11-driven disorders.从综合征线索到诊断:了解CARD11驱动的疾病。
Front Immunol. 2025 Jun 23;16:1626065. doi: 10.3389/fimmu.2025.1626065. eCollection 2025.
9
The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association.CARD11的蛋白激酶C反应性抑制结构域在NF-κB激活中发挥作用,以调节多种信号共因子的结合,这些共因子的结合对Bcl10和MALT1的依赖性各不相同。
Mol Cell Biol. 2008 Sep;28(18):5668-86. doi: 10.1128/MCB.00418-08. Epub 2008 Jul 14.
10
The dynamic distribution of CARD11 at the immunological synapse is regulated by the inhibitory kinesin GAKIN.CARD11 在免疫突触处的动态分布受抑制性驱动蛋白 GAKIN 调节。
Mol Cell. 2010 Dec 10;40(5):798-809. doi: 10.1016/j.molcel.2010.11.007.

本文引用的文献

1
QRICH1 suppresses pediatric T-cell acute lymphoblastic leukemia by inhibiting GRP78.QRICH1 通过抑制 GRP78 抑制小儿 T 细胞急性淋巴细胞白血病。
Cell Death Dis. 2024 Sep 4;15(9):646. doi: 10.1038/s41419-024-07040-7.
2
Small molecule inhibitors for cancer immunotherapy and associated biomarkers - the current status.小分子抑制剂在癌症免疫治疗及相关生物标志物中的应用现状。
Front Immunol. 2023 Oct 31;14:1297175. doi: 10.3389/fimmu.2023.1297175. eCollection 2023.
3
LAG-3 as the third checkpoint inhibitor.LAG-3 作为第三个检查点抑制剂。
Nat Immunol. 2023 Sep;24(9):1415-1422. doi: 10.1038/s41590-023-01569-z. Epub 2023 Jul 24.
4
A novel variant in the QRICH1 gene was identified in a patient with severe developmental delay.在一名患有严重发育迟缓的患者中发现了 QRICH1 基因的一种新变异。
Mol Genet Genomic Med. 2023 Aug;11(8):e2227. doi: 10.1002/mgg3.2227. Epub 2023 Jun 18.
5
From bench to bedside: the history and progress of CAR T cell therapy.从实验室到临床:嵌合抗原受体 T 细胞疗法的历史与进展。
Front Immunol. 2023 May 15;14:1188049. doi: 10.3389/fimmu.2023.1188049. eCollection 2023.
6
Function and targeting of MALT1 paracaspase in cancer.MALT1 副半胱氨酸蛋白酶在癌症中的功能和靶向性。
Cancer Treat Rev. 2023 Jun;117:102568. doi: 10.1016/j.ctrv.2023.102568. Epub 2023 Apr 26.
7
Elevated IgE from attenuated CARD11 signaling: lessons from atopic mice and humans.衰减的 CARD11 信号导致 IgE 升高:来自特应性小鼠和人类的经验教训。
Curr Opin Immunol. 2022 Dec;79:102255. doi: 10.1016/j.coi.2022.102255. Epub 2022 Nov 2.
8
Combining precision oncology and immunotherapy by targeting the MALT1 protease.通过靶向 MALT1 蛋白酶实现精准肿瘤学与免疫治疗的联合。
J Immunother Cancer. 2022 Oct;10(10). doi: 10.1136/jitc-2022-005442.
9
Kinetic proofreading through the multi-step activation of the ZAP70 kinase underlies early T cell ligand discrimination.动力学校对通过 ZAP70 激酶的多步激活来支撑早期 T 细胞配体的辨别。
Nat Immunol. 2022 Sep;23(9):1355-1364. doi: 10.1038/s41590-022-01288-x. Epub 2022 Aug 31.
10
Mechanistic impact of oligomer poisoning by dominant-negative CARD11 variants.显性负性CARD11变体导致的寡聚体中毒的机制影响
iScience. 2022 Jan 22;25(2):103810. doi: 10.1016/j.isci.2022.103810. eCollection 2022 Feb 18.